The effects of Ginger (Zinger offiicinale Roscoe) on the prevention of PVC in patients with palpitatio
Phase 2
Recruiting
- Conditions
- Palpitations.PalpitationsR00.2
- Registration Number
- IRCT20220516054874N13
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Patients with heart palpitations
The number of PVCs during one day less than 15% in the 24-hour Holter rhythm
Consent to admission to the study;
Exclusion Criteria
Previous history of heart palpitations
History of receiving medications for PVC
Structural heart disorder
Stomach ulcers or duodenal ulcers
Taking anticoagulants such as warfarin, aspirin and enoxaparin
Breastfeeding or pregnancy
Consumption of omega 3 (fish oil), ciprofloxacin, loratadine, citalopram, montelukast, and levothyroxine
Kidney stone
History of taking medicines containing ginger
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of PVCs during 24 h. Timepoint: Before intervention and 10 days after beginning the intervention. Method of measurement: 24-hour Holter rhythm.
- Secondary Outcome Measures
Name Time Method